Agape ATP Corporation (ATPC)
NASDAQ: ATPC
· Real-Time Price · USD
1.66
0.13 (8.50%)
At close: Jun 13, 2025, 3:59 PM
1.67
0.60%
After-hours: Jun 13, 2025, 05:04 PM EDT
Agape ATP Revenue Breakdown
Period Ending | Dec 31, 2024 |
---|---|
Energized Mineral Concentrate Revenue | 43.49K |
Energized Mineral Concentrate Revenue Growth | n/a |
Health and Wellness Services Revenue | 207.55K |
Health and Wellness Services Revenue Growth | n/a |
Ionized Cal Mag Revenue | 388 |
Ionized Cal Mag Revenue Growth | n/a |
Product Health Therapies Revenue | 913.3K |
Product Health Therapies Revenue Growth | n/a |
Operating Expense Breakdown
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 876.69K | 1.03M | 732.29K | 647.15K | 914.36K | 1.25M | 551.81K | 555.54K | 706.29K | 823.07K | 699.45K | 593.51K | 607.76K | 804.8K | 529.62K | 555.47K | 566.7K | 853.75K | 815.52K | 1.01M | 159.52K | 204.93K | 144.28K | 468.42K | 28.23K | 24.48K | 38.59K | 233.19K | 23.98K | 4.42K | 90.76K | 75.36K | n/a | n/a | n/a |
Selling, General, and Administrative Revenue Growth | -14.56% | +40.12% | +13.16% | -29.22% | -27.09% | +127.28% | -0.67% | -21.34% | -14.19% | +17.67% | +17.85% | -2.35% | -24.48% | +51.96% | -4.65% | -1.98% | -33.62% | +4.69% | -18.94% | +530.73% | -22.16% | +42.03% | -69.20% | +1559.53% | +15.31% | -36.56% | -83.45% | +872.39% | +442.68% | -95.13% | +20.44% | n/a | n/a | n/a | n/a |
Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales and Marketing Revenue | 71K | 44.11K | 48.48K | 45.34K | 59.69K | 457.74K | 63.29K | 86.07K | 110.04K | 152.48K | 243.43K | 142.14K | 228.72K | 153.11K | 159.67K | 193.61K | 204.55K | 255.14K | 460.25K | 491.39K | n/a | 1.68K | 338 | 6.5K | n/a | n/a | n/a | 265.68K | n/a | n/a | n/a | 75.36K | n/a | n/a | n/a |
Sales and Marketing Revenue Growth | +60.97% | -9.01% | +6.91% | -24.04% | -86.96% | +623.28% | -26.47% | -21.78% | -27.83% | -37.36% | +71.25% | -37.85% | +49.38% | -4.11% | -17.53% | -5.35% | -19.83% | -44.57% | -6.34% | n/a | -100.00% | +397.04% | -94.80% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a |